The vaccine 'HNVAC', manufactured in cell culture by Bharat Biotech, is the first such medicine developed in India, experts said on Tuesday.
As cell-culture manufacturing is a highly sterile and controlled manufacturing process instead of eggs, the vaccine is proved to be safe and well tolerated after several extensive clinical trials.
Bharat Biotech's Chairman and Managing Director, Dr Krishna Ella said: "While there is widespread and growing concern over H1N1, there are number of people who did not get a flu shot last year.
"Our goal right now is to make the flu vaccine easily accessible and at affordable cost to high risk groups."
Earlier this month, the firm received the approval from the Drugs Controller General of India to launch HNVAC vaccine, which was developed with approved strains from WHO and CDC Atlanta.
Swine flu has caused concerns not only in India but also in many other countries. Hundreds of people have died due to the absence of effective medicines and vaccines to check the contagious fever.
Researches to develop a preventive vaccine for this are progressing in many countries.
Swine Flu - Vaccination Fraud Debunked
No comments:
Post a Comment